Screener — stockrow

Abbott Laboratories

ABT Healthcare · Medical Devices · US

$110.08 −11.9% 1Y

Low $81.97 High $132.03

Abbott Laboratories is a healthcare-products company headquartered in North Chicago and led by Chief Executive Officer Robert Ford. It discovers, develops, manufactures and sells products across four businesses: Medical Devices, Diagnostic Products, Nutritional Products and Established Pharmaceutical Products.

Market cap $196.6B

Revenue growth (Q) +14.5%

EPS growth (Q) −43.6%

FCF growth (Q) +28.9%

Revenue growth (next yr) +12.7%

Net margin 9.75%

ROE 9.14%

P/E 41.1×

Forward P/E 35.1×

P/FCF 28.3×

Dividend yield 2.29%

Insider ownership 0.83%

Insider buys / sells (12M) $4.4M $47.5M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$43.7B	$40.1B	$42.0B	$44.3B	$48.2B
EPS	$3.91	$3.26	$7.64	$3.72	$2.68
Free cash flow	$7.8B	$5.1B	$6.4B	$7.4B	$6.8B
Net debt	$6.6B	$7.4B	$6.2B	$4.0B	$26.9B

Medtronic PLC

MDT Healthcare · Medical Devices · IE

$101.77 +13.0% 1Y

Low $73.31 High $106.33

Medtronic is a healthcare technology company headquartered in Galway, Ireland. Founded in 1949, it develops, manufactures, distributes and sells device-based medical therapies and related services.

Market cap $134.1B

Revenue growth (Q) +13.7%

EPS growth (Q) +40.7%

FCF growth (Q) +120.9%

Revenue growth (next yr) +7.17%

Net margin 13.9%

ROE 10.6%

P/E 24.9×

Forward P/E 20.8×

P/FCF 21.2×

Dividend yield 2.81%

Insider ownership 0.00%

Insider buys / sells (12M) — $14.7M

Reported	FY2023	FY2024	FY2025	FY2026	TTM
Revenue	$31.2B	$32.4B	$33.5B	$36.4B	$37.5B
EPS	$2.82	$2.76	$3.61	$3.73	$4.06
Free cash flow	$4.6B	$5.2B	$5.2B	$5.4B	$6.1B
Net debt	$16.4B	$17.0B	$19.6B	$18.7B	$19.3B

Stryker Corporation

SYK Healthcare · Medical Devices · US

$324.26 −8.35% 1Y

Low $267.00 High $389.33

Stryker is a medical technology company that sells equipment, implants and other products used in hospitals and other healthcare facilities. Its businesses cover medical and surgical care, treatments for vascular and neurological conditions, and orthopaedics.

Market cap $127.6B

Revenue growth (Q) +7.64%

EPS growth (Q) −11.8%

FCF growth (Q) −19.4%

Revenue growth (next yr) +6.77%

Net margin 13.8%

ROE 16.0%

P/E 34.3×

Forward P/E 24.6×

P/FCF 28.1×

Dividend yield 1.09%

Insider ownership 6.25%

Insider buys / sells (12M) — $401.5M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$18.4B	$20.5B	$22.6B	$25.1B	$26.3B
EPS	$6.17	$8.25	$7.76	$8.40	$9.39
Free cash flow	$2.0B	$3.1B	$3.5B	$4.3B	$4.4B
Net debt	$11.1B	$9.9B	$9.1B	$11.8B	$11.7B

Boston Scientific Corporation

BSX Healthcare · Medical Devices · US

$42.73 −56.9% 1Y

Low $39.57 High $105.65

Boston Scientific develops, manufactures and markets medical devices used by physicians and other medical professionals. Its products help diagnose and treat conditions affecting the heart and blood vessels, digestive and urinary systems, and nervous system, as well as some cancers.

Market cap $64.7B

Revenue growth (Q) +1.44%

EPS growth (Q) −21.7%

FCF growth (Q) −25.3%

Revenue growth (next yr) +4.44%

Net margin 16.6%

ROE 14.2%

P/E 18.0×

Forward P/E 17.0×

P/FCF 18.6×

Dividend yield —

Insider ownership 0.60%

Insider buys / sells (12M) $10.0M $18.1M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$12.7B	$14.2B	$16.7B	$20.1B	$21.1B
EPS	$0.45	$1.07	$1.25	$1.94	$2.36
Free cash flow	$950.0M	$1.8B	$2.6B	$3.7B	$3.3B
Net debt	$8.0B	$8.2B	$10.3B	$9.5B	$11.3B

Edwards Lifesciences Corporation

EW Healthcare · Medical Devices · US

$101.94 +23.7% 1Y

Low $74.66 High $104.17

Edwards Lifesciences makes medical devices for structural heart disease, with a focus on repairing or replacing heart valves. A faulty valve can disrupt the heart’s function or blood flow.

Market cap $58.1B

Revenue growth (Q) +10.5%

EPS growth (Q) +4.36%

FCF growth (Q) −1.84%

Revenue growth (next yr) +11.4%

Net margin 15.3%

ROE 9.65%

P/E 57.8×

Forward P/E 36.5×

P/FCF 42.1×

Dividend yield —

Insider ownership 1.20%

Insider buys / sells (12M) — $27.7M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$4.5B	$5.0B	$5.4B	$6.1B	$6.7B
EPS	$2.44	$2.30	$6.97	$1.83	$1.76
Free cash flow	$953.4M	$629.5M	$259.9M	$1.3B	$1.4B
Net debt	−$619.0M	−$1.0B	−$3.4B	−$3.6B	−$4.0B

Stockrow Weekly